PB2196: EQUATOR: A PIVOTAL PHASE 3 DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ITOLIZUMAB IN COMBINATION WITH CORTICOSTEROIDS FOR THE INITIAL TREATMENT OF ACUTE GRAFT-VERSUS-HOST DISEASE. (23rd June 2022) - Koreth, J.; Kean, L.; Chinn, L.; Acevedo, L. M.; Bandman, O.; Rothman, J.; Connelly, S.; Thomas, D.; Cutler, C.